Data on biopharma deal-making in 2015

Biopharma deal-making in 2015 featured substantial consolidation and bigger transaction values than ever.

Like Comment

Biopharma deal-making in 2015. a | Mergers and acquisitions (M&As). The chart includes full-company acquisitions and purchases of majority stakes. The 'number of deals' total includes deals that did not have a disclosed value. b | Partnerships. c | Breakdown of partnerships by therapeutic area. Deals involving more than one therapy area may be counted multiple times, if applicable. Source: Medtrack.

Source article: Micklus, A. & Muntner, S. Biopharma deal-making in 2015: changing the pharma landscape. Nature Reviews Drug Discovery 15,78–79 (2016)

Go to the profile of Nature Reviews Drug Discovery

Nature Reviews Drug Discovery

Nature Reviews Drug Discovery, one of the two journals in which Biopharma Dealmakers appears in print, is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to peer-reviewed articles covering the field, each issue includes news stories that investigate hot topics, summaries of key primary research papers and analysis of industry trends.

No comments yet.